↓ Skip to main content

PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours

Overview of attention for article published in BMC Cancer, October 2012
Altmetric Badge

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
56 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours
Published in
BMC Cancer, October 2012
DOI 10.1186/1471-2407-12-496
Pubmed ID
Authors

Mark J McKeage, Michael B Jameson, Ramesh K Ramanathan, Joseph Rajendran, Yongchuan Gu, William R Wilson, Teresa J Melink, N Simon Tchekmedyian

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 55 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 18%
Student > Master 8 14%
Student > Bachelor 7 13%
Student > Ph. D. Student 6 11%
Student > Doctoral Student 4 7%
Other 11 20%
Unknown 10 18%
Readers by discipline Count As %
Medicine and Dentistry 15 27%
Biochemistry, Genetics and Molecular Biology 12 21%
Agricultural and Biological Sciences 7 13%
Chemistry 4 7%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Other 6 11%
Unknown 10 18%